Characterization of the 5′ noncoding and structural region of the hepatitis C virus genome from patients with non-A, non-B hepatitis responding differently to interferon treatment

Takahide Nakazawa, Nobuyuki Kato, Showgo Ohkoshi, Akitaka Shibuya, Kunitada Shimotohno

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

We examined 14 patients with hepatitis C caused by infection with the hepatitis C virus-II genotype to understand differences in responsiveness to interferon. The patients were classified into two groups according to their response to interferon: eight responding and six non-responding patients. The 5′ noncoding and structural regions of the hepatitis C virus-II genome from each patient specimen were amplified by reverse transcription followed by the polymerase chain reaction. The nucleotide sequences of these amplified DNAs were then determined. By comparing the nucleotide sequences and the deduced amino acid sequences of samples from both groups, no group-specific sequence was observed in the analyzed regions despite the presence of considerable sequence diversity. However, additional cysteine residues were observed in half the responding group. The degree of micro-heterogeneity in hypervariable region 1 of the hepatitis C virus in relation to the sensitivity to interferon treatment was also examined; however, no significant correlation was observed. In addition, frequent alterations in the amino acid sequences were observed in hypervariable region 1 during the course of interferon treatment.

Original languageEnglish
Pages (from-to)623-629
Number of pages7
JournalJournal of Hepatology
Volume20
Issue number5
DOIs
Publication statusPublished - 1994

Keywords

  • Envelope region
  • Hepatitis C virus
  • Hypervariable region
  • Interferon treatment
  • Sequence diversity
  • Sequence variability

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Characterization of the 5′ noncoding and structural region of the hepatitis C virus genome from patients with non-A, non-B hepatitis responding differently to interferon treatment'. Together they form a unique fingerprint.

  • Cite this